Skip to main content

EXPLORE

Verisyse® Phakic IOL

Explore the myopia correction provided by an anterior chamber lens. 

BAERVELDT® Glaucoma Implants

Give your glaucoma patients a proven solution for IOP control. 

DISCOVER

ifs

Surgical Systems

Find out more about our platforms for LASIK and cataract surgery.

Customer Support

CUSTOMER SUPPORT

Explore resources for equipment education and practice development, as well as our online tools.

INDICATIONS AND IMPORTANT SAFETY INFORMATION

Rx Only

VERISYSE® PHAKIC IOL
INDICATIONS

Verisyse® Intraocular Lenses are indicated for the reduction or elimination of myopia in adults with myopia ranging from -5.0 to -20.0 diopters with greater than or equal to 2.5 diopters of astigmatism at the spectacle plane and whose eyes have an anterior chamber depth greater than or equal to 3.2 millimeters; and, patients with documented stability of refraction for the prior 6 months, as demonstrated by spherical equivalent change of less than or equal to 0.50 diopters.

WARNINGS

If you have any of the following conditions, be sure to discuss them with your doctor: congenital bilateral cataracts, recurrent ocular inflammation, history of ocular diseases, previous history of retinal detachment, only one eye with potentially good vision, medically uncontrollable glaucoma, corneal endothelial dystrophy, proliferative diabetic retinopathy.

See Full Indications and Important Safety Information.

BAERVELDT® GLAUCOMA IMPLANTS
INDICATIONS

For use in patients (with prior vitrectomy for Pars Plana) with medically uncontrollable glaucoma and poor surgical prognosis, such as, but not limited to: neovascular glaucoma, aphakic/pseudophakic glaucomas, patients who have failed conventional surgery, congenital glaucomas and secondary glaucomas due to uveitis, epithelial downgrowth, etc. 

WARNINGS

Do not use the device if sterile package integrity has been compromised. Do not resterilize the implant by any method. Do not reuse the implant. Do not store at temperatures above 45°C (113°F).

See Full Indications and Important Safety Information.

ATTENTION

Reference the Directions for Use labeling for a complete listing of Indications and Important Safety Information.

PP2018MLT4018